Novus’s Positive Financial Performance and Market Position Highlight Novus's 1Q 2025

About this update from Novus Acquisition & Development Corp.

Novus Acquisition & Development Corp, operating as Novus Cannabis MedPlan (OTC: NDEV ), is a leading national carrier of supplemental health insurance plans and a pioneer in incorporating cannabis coverage for recreational and medicinal users.  The company has released its interim financial report for 2025, highlighting positive momentum across key financial indicators.. Key Financial Performance Novus's growth without external financing is driven by its Benefit Monetization Ratio (BMR), which impacts stock pricing in the insurance index.  Investors can use Novus's BMR to assess the company's potential for building shareholder value and may find the stock price to be undervalued. The company demonstrates a solid financial footing, underscored by the fact that no insider shares have been sold over the past three years, signaling strong internal confidence. Gross Revenue has exhibited an increase of 8.7% compared to December 31, 2024, reflecting healthy market traction.  Operational efficiency and profitability have seen notable improvements, with EBITDA increasing by a significant 13.8% compared to March 31, 2024. The company also maintains a liquidity position, as Cash and Cash Equivalents grew by 2.53% between the financial reporting periods ending March 31, 2025, and March 31, 2024, providing ample financial flexibility for future initiatives. Further strengthening the financial profile is the absence of any convertible debt, which simplifies the capital structure. Additionally, the company maintains transparency regarding a $165,213 debt owed to CEO Frank Labrozzi, with no plans for exercising the call provision or any equity conversion features associated with this debt. Finally, to ensure market stability, vendors holding treasury-issued stock are contractually limited to selling no more than 15% of the average daily trading volume over the preceding 30 days. Strategic Advantages That Drive Novus's Growth Trajectory Novus’s interim 2025 report underscores its adept navigation of the evolving cannabis regulatory environment. The company's business model, intentionally structured to operate independently of federal cannabis regulations by focusing on state-level policy sales, provides a significant strategic advantage. Novus is actively leveraging favorable regulatory shifts, including the Compassionate Care Act and the Veterans Cannabis Use for Safe Healing Act, to broaden its market penetration. Furthermore, the establishment of key strategic alliances with influential entities such as PRAM and Compass Health is accelerating the adoption and integration of Novus' innovative cannabis-integrated health insurance plans within the broader healthcare landscape. The company's solid financial foundation, marked by increased revenue, shareholder equity, and cash reserves, provides a robust platform for sustained future growth within the dynamic cannabis market. Novus's proactive approach to regulatory changes, coupled with its expanding network and strategic partnerships, positions it as a key player in facilitating access to cannabis benefits through health insurance. This unique market position and forward-thinking strategy underscore Novus Acquisition & Development Corp.'s potential for continued success and value creation in the evolving cannabis industry. About Novus Further Research: Financial Filings:  Click Here Quote: Click Here Investor's Page : Click Here  Novus (NDEV) operates through its wholly-owned subsidiary, WCIG Insurance Services, Inc. The company provides health plans as a health insurance carrier in states with legal medical marijuana programs. Novus' business model is based on receiving insurance premiums and does not involve the cultivation, distribution, or sale of cannabis or cannabis-related products. Forward-Looking Statements This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. Novus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future.     Investor Contact Information Investor Website 855-228-7355  Email: [email protected]

View stock analysis, news, and events for Novus Acquisition & Development Corp.